BEAT
NASDAQ
$0.59
HeartBeam Inc (BEAT)
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
This company is also listed under the following ticker: BEATW.
Website: https://www.heartbeam.comSector:
Healthcare
Industry:
Health Information Services
Strong Buy
Target: $3.38 (+469.91%)
Market Cap
$27M
Free Cash Flow Yield
-51.44%
Beta (5Y)
1.35
Price Chart
Valuation
Market Cap$27M
P/B50.52
Profitability
EBITDA-$20M
EPS-$0.55
Financial Health
Free Cash Flow Yield-51.44%
Growth & Risk
Beta (5Y)1.35
Sharpe Ratio0.14